About Halflife Labs

Built by someone
who needed it.

Halflife started as a personal tool. It became a data infrastructure company.

The Founder

Ziad Soliman

I started Halflife because I was the person who needed it and couldn't find it.

I was running tirzepatide alongside BPC-157, CJC-1295, and ipamorelin — managing three different apps, a spreadsheet for reconstitution math, and a notes app for injection sites. Every week I was manually calculating how active each compound was, when to inject, how much to draw. It was consuming and error-prone.

I looked at every existing tracker. Shotsy handled GLP-1s but ignored peptides entirely. Peptide apps didn't touch hormones or GLP-1s. Nothing understood what it meant to run multiple compounds with completely different half-lives, frequencies, and reconstitution requirements simultaneously.

So I built Halflife. Not as an app company — as the data infrastructure layer this entire category has been missing. Every compound half-life is sourced directly from FDA prescribing labels and peer-reviewed pharmacokinetic studies. The curves you see in the app are the same math used in clinical pharmacology.

The real opportunity isn't the app. It's the longitudinal real-world dataset it generates — the first of its kind for stacked GLP-1, peptide, and hormone protocols. That dataset is what will change how this entire category is understood.

Based in
Vienna, Austria
Contact
contact@halflife-labs.com
Partner with Halflife Labs →
Ziad Soliman — Founder, Halflife Labs
Ziad Soliman
Founder & CEO, Halflife Labs
The Mission

Build the real-world evidence layer that the GLP-1 and peptide generation deserves — and make it available to everyone running a protocol.

The clinical trials that established GLP-1 dosing protocols enrolled highly controlled populations with weekly blood draws and clinical oversight. Real-world users stack compounds, miss doses, change protocols, and get results that look nothing like the trials. We're building the infrastructure to understand what actually happens.

📱

The App

The only tracker built for stackers — GLP-1s, peptides, and TRT in a single protocol view. Powered by FDA-sourced pharmacokinetic data.

🔬

The Research

Longitudinal real-world data from opted-in users running stacked protocols. The dataset that doesn't exist anywhere else.

🏥

The Platform

API infrastructure for telehealth platforms, compounding pharmacies, and pharmaceutical data licensing partners.

Track your protocol.
Power the research.

Free to download. Pro unlocks everything.

↓ Download on App Store